Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Multilevel factors shaping blinatumomab delivery across diverse LMICs
Multilevel factors shaping blinatumomab delivery across diverse LMICs

AACR 2009: Ovarian cancer biomarkers

Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospital, Harvard Medical School, USA
AACR 2009: Ovarian cancer biomarkers ( Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospital, Harvard Medical School, USA )
1 May 2009

AACR 2009: Genetics of pleuropulmonary blastoma

Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical Center, USA
AACR 2009: Genetics of pleuropulmonary blastoma ( Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical Center, USA )
1 May 2009

AACR 2009: Designer T-Cells tackle prostate cancer

Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston University School of Medicine, USA
AACR 2009: Designer T-Cells tackle prostate cancer ( Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston University School of Medicine, USA )
30 Apr 2009

AACR 2009: Genetic variants in microRNA processing pathway genes and ovarian cancer risk

Professor Xifeng Wu - Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, USA
AACR 2009: Genetic variants in microRNA processing pathway genes and ovarian cancer risk ( Professor Xifeng Wu - Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, USA )
30 Apr 2009

AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia

Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia ( Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA )
30 Apr 2009

AACR 2009: Genetic prostate cancer risk

Dr Sunita Setlur - Brigham and Women's Hospital, Harvard Medical School, USA
AACR 2009: Genetic prostate cancer risk ( Dr Sunita Setlur - Brigham and Women's Hospital, Harvard Medical School, USA )
30 Apr 2009

AACR 2009: DNA profiling for bladder cancer

Dr Gangning Liang - Associate Professor of Research, Department of Urology, University of Southern California
AACR 2009: DNA profiling for bladder cancer ( Dr Gangning Liang - Associate Professor of Research, Department of Urology, University of Southern California )
30 Apr 2009

AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells

Anthony Williams - Keck School of Medicine, University of Southern California
AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells ( Anthony Williams - Keck School of Medicine, University of Southern California )
30 Apr 2009

AACR 2009: DMC exerts antiangiogenic effects on the tumour vasculature

Professor Florence Hofman - Keck School of Medicine, University of Southern California
AACR 2009: DMC exerts antiangiogenic effects on the tumour vasculature ( Professor Florence Hofman - Keck School of Medicine, University of Southern California )
30 Apr 2009

AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer

Dr Mamta Gupta - Mayo Clinic Cancer Center, USA
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer ( Dr Mamta Gupta - Mayo Clinic Cancer Center, USA )
30 Apr 2009

AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease

Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )
30 Apr 2009

AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer

Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech
AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer ( Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech )
30 Apr 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation